Dr. Edna Iris Flores, MD

Dr. Flores practices at Ccare in Nashville, Tennessee.

Dr. Flores' NPI, 1396994604, was assigned on September 10, 2008. Dr. Flores graduated from Joe R. & Teresa Lozano Long School of Medicine in 2007. Dr. Flores' California license number on file is 312009.

Dr. Flores' primary practice is Ccare, at 104 Woodmont Blvd, Nashville, TN 37205 in Davidson County. The practice phone is (559) 326-1222.

Dr. Flores' primary practice is Ccare in Nashville, Tennessee. Dr. Flores is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is California Cancer Associates for Research and Excellence (cCARE). Dmand AI also links Dr. Flores to 3 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Flores practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Flores' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Flores is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Flores' licenses on file in 2 states: California and Texas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphedema and lymphoma among the conditions Dr. Flores treats.

CMS data shows 67,887 Medicare services from Dr. Flores across 35 procedure codes in 2024, for 419 Medicare patients. Medicare paid $582,825 for them.

CMS counts 419 Medicare patients who saw Dr. Flores in 2024. The largest group is 75 to 84, with 174 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 19% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Flores' median patient age at 70, with 70% women.

In 2024, Dr. Flores wrote 1,083 Medicare Part D claims for 211 patients. 82% of them were for generic drugs. CMS names the drug for 838 of them, across 31 drugs with 11 or more claims each, at $2,551,236 in total drug cost. In 2023, CMS named 575 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Flores for performance year 2024, reported as part of a group. Dr. Flores accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Flores as offering telehealth.

Dmand AI links 1 paper to Dr. Flores in 2015. Dr. Flores' most frequent co-authors are Kelly J. Bethel, MD, Julia Y. Li, MD and Edward F. McClay, MD.

CMS Open Payments shows 1,347 general payments to Dr. Flores from 99 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Novartis Pharmaceuticals Corporation paid the most, $9,941.

Dr. Flores graduated from Joe R. & Teresa Lozano Long School of Medicine in 2007.

Dr. Flores is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.